Dr. Marie-Louise Schuttelaar Dermatoloog

Wetenschappelijke publicaties

• Case report: Recall dermatitis at patch-test sites after oral provocation with mesalazine
• Disease characteristics, comorbidities, treatment patterns and quality of life impact in children <12 years old with atopic dermatitis: Interim results from the PEDISTAD Real-World Registry
• Efficacy and safety of tralokinumab in adolescents with moderate-to-severe atopic dermatitis: results of the phase 3 ECZTRA 6 trial